Frontiers in Psychiatry | Mood Disorders

Original Research

Published on 14 Nov 2024

Elevated remnant cholesterol and the risk of prevalent major depressive disorder: a nationwide population-based study

in Mood Disorders

Shiyi Tao
Lintong Yu
Ji Wu
Deshuang Yang
Xuanchun Huang
Tiantian Xue

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1495467

1,586 views

Original Research

Published on 14 Nov 2024

Neurofilament light chain plasma levels in major depressive disorder: a brief research report

in Mood Disorders

Carlos Fernández-Pereira
María de los Ángeles Fernández-Ceballos
José Manuel Olivares
José M. Prieto-González
Roberto Carlos Agís-Balboa

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1476248

1,328 views
1 citation

Systematic Review

Published on 12 Nov 2024

The influence of physical exercise on negative emotions in adolescents: a meta-analysis

in Mood Disorders

Tong Wang
Weicheng Li
Jiaxin Deng
Qiubo Zhang
Yongfeng Liu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1457931

1,998 views
1 citation

Original Research

Published on 07 Nov 2024

Real-world clinical determinants of alcohol dependence in outpatients with bipolar disorder: a multicenter treatment survey for bipolar disorder in psychiatric outpatient clinics with 2,392 participants

in Mood Disorders

Keita Tokumitsu
Norio Sugawara
Naoto Adachi
Yukihisa Kubota
Yoichiro Watanabe
Kazuhira Miki
Takaharu Azekawa
Koji Edagawa
Eiichi Katsumoto
Seiji Hongo

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1434810

2,000 views

Mini Review

Published on 05 Nov 2024

The gut microbiota-brain connection: insights into major depressive disorder and bipolar disorder

in Mood Disorders

Jia Zhao
Jiaoyan Liu
Jianguo Feng
Xing Liu
Qinxue Hu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1421490

2,865 views
1 citation

Original Research

Published on 05 Nov 2024

Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) with depressive symptoms: recent findings from NHANES 2005–2018

in Mood Disorders

Chunyu Yan
He Wang
Changxing Liu
Jiamei Fu
Yabin Zhou

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1467142

2,495 views

Opinion

Published on 31 Oct 2024

Multifamily therapy in difficult-to-treat depression: an integrated and promising approach to rethinking clinical strategies

in Mood Disorders

Walter Paganin

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1484440

2,286 views
1 citation

Correction

Published on 28 Oct 2024

Corrigendum: Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?

in Mood Disorders

Magdalena Więdłocha
Piotr Marcinowicz
Jan Komarnicki
Małgorzata Tobiaszewska
Weronika Dębowska
Marta Dębowska
Agata Szulc

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1507504

909 views
1 citation

Original Research

Published on 17 Oct 2024

When you avoid your feelings, you may feel even worse: how depersonalization puts you at risk of depression

in Mood Disorders

Dominika Fortuna
Krystyna Golonka

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1481439

1,875 views

Original Research

Published on 17 Oct 2024

Prediction of pharmacological treatment efficacy using electroencephalography-based salience network in patients with major depressive disorder

in Mood Disorders

Kang-Min Choi
Taegyeong Lee
Chang-Hwan Im
Seung-Hwan Lee

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1469645

1,331 views

Original Research

Published on 15 Oct 2024

Cognitive function characteristics and influencing factors in patients with depressive disorders: a 5-year follow-up report based on the epidemiological survey of mental disorders in Shandong Province, China

in Mood Disorders

Ziang Lin
Qian Wang
Xiaojing Li
Can Wang
Ruzhan Wang
Chenghui Wang
Hao Ding
Liju Qian
Xiaona Wan
Xue Tian

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1434659

970 views

Original Research

Published on 14 Oct 2024

The impact of sleep disturbances on treatment efficacy and prognosis in patients with depressive and anxiety disorders

in Mood Disorders

Qingyu Zhang
Maoqing Tong
Yunxin Ji
Yanbin Hou
Zongze Lou
Danjuan Wu
Yuwei Mi
Pingping Miu
Jiaxin Tian
Zhenzhen Zhu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1432538

1,570 views

Review

Published on 14 Oct 2024

From antidepressants and psychotherapy to oxytocin, vagus nerve stimulation, ketamine and psychedelics: how established and novel treatments can improve social functioning in major depression

in Mood Disorders

Aleksandra Kupferberg
Gregor Hasler

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1372650

4,019 views

Original Research

Published on 10 Oct 2024

The association between borderline personality disorder, childhood trauma, neuroticism, and self-rated or clinician-rated functional impairment in euthymic bipolar disorder-1 patients

in Mood Disorders

Esat Fahri Aydın
Tuğba Koca Laçin

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1444583

1,921 views

Original Research

Published on 10 Oct 2024

Higher atherogenic index of plasma is associated with increased major depressive disorder: insights from a nationally representative study

in Mood Disorders

Shiyi Tao
Lintong Yu
Jun Li
Xuanchun Huang
Tiantian Xue
Deshuang Yang
Yuqing Tan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1441119

2,002 views

Original Research

Published on 07 Oct 2024

Estimating the benefit of esketamine nasal spray versus real-world treatment on patient-reported functional remission: results from the ICEBERG study

in Mood Disorders

Albino J. Oliveira-Maia
Benoît Rive
Yordan Godinov
Siobhán Mulhern-Haughey

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1459633

1,625 views
3 citations